The Nuclear Receptor AhR Controls Bone Homeostasis by Regulating Osteoclast Differentiation via the RANK/c-Fos Signaling Axis (original) (raw)
Environmental Toxicants May Modulate Osteoblast Differentiation by a Mechanism Involving the Aryl Hydrocarbon Receptor
Thomas Gasiewicz
Journal of Bone and Mineral Research, 2007
View PDFchevron_right
Inhibition of osteoclast differentiation by polycyclic aryl hydrocarbons is dependent on cell density and RANKL concentration
Howard Tenenbaum
Biochemical Pharmacology, 2005
View PDFchevron_right
Carbon Monoxide Inhibits Receptor Activator of NF-κB (RANKL)-Induced Osteoclastogenesis
Ching-feng Weng
Cellular Physiology and Biochemistry, 2015
View PDFchevron_right
Nicotinic acetylcholine receptors modulate osteoclastogenesis
Peter Mandl
Arthritis Research & Therapy, 2016
View PDFchevron_right
NF-κB p50 and p52 Regulate Receptor Activator of NF-κB Ligand (RANKL) and Tumor Necrosis Factor-induced Osteoclast Precursor Differentiation by Activating c-Fos and NFATc1
Koichi Matsuo
Journal of Biological Chemistry, 2007
View PDFchevron_right
New insights to the role of aryl hydrocarbon receptor in bone phenotype and in dioxin-induced modulation of bone microarchitecture and material properties
Matti Viluksela, Helen Hakansson
Toxicology and Applied Pharmacology, 2013
View PDFchevron_right
Osteoblasts Provide a Suitable Microenvironment for the Action of Receptor Activator of Nuclear Factor-κB Ligand
Nobuyuki Udagawa, Akihiro Hosoya
Endocrinology, 2006
View PDFchevron_right
Estrogen Decreases Osteoclast Formation by Down-regulating Receptor Activator of NF-kappa B Ligand (RANKL)-induced JNK Activation
Simone Cenci
Journal of Biological Chemistry, 2001
View PDFchevron_right
Resveratrol Rescue Indoxyl Sulfate-Induced Deterioration of Osteoblastogenesis via the Aryl Hydrocarbon Receptor /MAPK Pathway
Hui-Wen Chiu
International Journal of Molecular Sciences, 2020
View PDFchevron_right
Colony-Stimulating Factor-1 (CSF-1) Directly Inhibits Receptor Activator of Nuclear Factor-κB Ligand (RANKL) Expression by Osteoblasts
Brent Wagner
Endocrinology, 2009
View PDFchevron_right
Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand-induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+-nuclear fact
Fan Yang
Journal of Bone and Mineral Research, 2012
View PDFchevron_right
The Paired-box Homeodomain Transcription Factor Pax6 Binds to the Upstream Region of the TRAP Gene Promoter and Suppresses Receptor Activator of NF- B Ligand (RANKL)-induced Osteoclast Differentiation
Gerald Atkins, David Findlay
Journal of Biological Chemistry, 2013
View PDFchevron_right
RANK is the Intrinsic Hematopoietic Cell Surface Receptor That Controls Osteoclastogenesis and Regulation of Bone Mass and Calcium Metabolism
James McCabe
Proceedings of the …, 2000
View PDFchevron_right
Activation of protein kinase C accelerates murine osteoclastogenesis partly via transactivation of RANK gene through functional AP-1 responsive element in RANK gene promoter
Yukihiro Kohara
Biochemical and Biophysical Research Communications, 2019
View PDFchevron_right
Up-regulation of osteopontin expression by aryl hydrocarbon receptor via both ligand-dependent and ligand-independent pathways in lung cancer
Jiunn-liang Ko
Gene, 2012
View PDFchevron_right
Concentration and Duration of Indoxyl Sulfate Exposure Affects Osteoclastogenesis by Regulating NFATc1 via Aryl Hydrocarbon Receptor
Paik Seong Lim
International Journal of Molecular Sciences
View PDFchevron_right
Interactomics profiling of the negative regulatory function of carbon monoxide on RANKL-treated RAW 264.7 cells during osteoclastogenesis
Min-Jen Tseng
BMC Systems Biology, 2014
View PDFchevron_right
Various roles of heme oxygenase-1 in response of bone marrow macrophages to RANKL and in the early stage of osteoclastogenesis
Ewelina Józefczuk
Scientific Reports
View PDFchevron_right
The Paired-box Homeodomain Transcription Factor Pax6 Binds to the Upstream Region of the TRAP Gene Promoter and Suppresses Receptor Activator of NF-κB Ligand (RANKL)-induced Osteoclast Differentiation
David Findlay
Journal of Biological Chemistry, 2013
View PDFchevron_right
Advances in the Regulation of Osteoclasts and Osteoclast Functions
Brendan Boyce
Journal of Dental Research, 2013
View PDFchevron_right
Nicotinic acetylcholine receptor activation completely blocks osteoclastogenesis by interfering with osteoclast precursor differentiation in vitro
Torbjørn Breivik
Annals of the Rheumatic Diseases, 2011
View PDFchevron_right
The Pivotal Role of the Alternative NF-κB Pathway in Maintenance of Basal Bone Homeostasis and Osteoclastogenesis
Neil Alles
Journal of Bone and Mineral Research, 2009
View PDFchevron_right
Commitment and Differentiation of Osteoclast Precursor Cells by the Sequential Expression of C-Fms and Receptor Activator of Nuclear Factor κb (Rank) Receptors
Kenneth Brasel
Journal of Experimental Medicine, 1999
View PDFchevron_right
RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis
Mori Naga
Biochemical and …, 1998
View PDFchevron_right
Phenethyl isothiocyanate suppresses receptor activator of NF-kappaB ligand (RANKL)-induced osteoclastogenesis by blocking activation of ERK1/2 and p38 MAPK in RAW264.7 macrophages
Michael Muse
BioFactors, 2007
View PDFchevron_right
Tumor necrosis factor-? mediates RANK ligand stimulation of osteoclast differentiation by an autocrine mechanism
Katharina Tschoep
Journal of Cellular Biochemistry, 2001
View PDFchevron_right
AP‐1 and Mitf interact with NFATc1 to stimulate cathepsin K promoter activity in osteoclast precursors
Mireya Hernandez
Journal of Cellular Biochemistry, 2019
View PDFchevron_right
TNF-related apoptosis-inducing ligand (TRAIL) blocks osteoclastic differentiation induced by RANKL plus M-CSF
Giorgio Zauli
Blood, 2004
View PDFchevron_right
Induction and Activation of the Transcription Factor NFATc1 (NFAT2) Integrate RANKL Signaling in Terminal Differentiation of Osteoclasts
Hiroki Yoshida
Developmental Cell, 2002
View PDFchevron_right
Protective Effects of Estradiol on Ethanol-Induced Bone Loss Involve Inhibition of Reactive Oxygen Species Generation in Osteoblasts and Downstream Activation of the Extracellular Signal-Regulated Kinase/Signal Transducer and Activator of Transcription 3/Receptor Activator of Nuclear Factor- B Li...
Jin-ran Chen
Journal of Pharmacology and Experimental Therapeutics, 2007
View PDFchevron_right
Inhibition of receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclast formation by pyrroloquinoline quinine (PQQ)
Abedul Haque
Immunology Letters, 2012
View PDFchevron_right
Targeted Deletion of a Distant Transcriptional Enhancer of the Receptor Activator of Nuclear Factor-κB Ligand Gene Reduces Bone Remodeling and Increases Bone Mass
Carlo Galli
Endocrinology, 2013
View PDFchevron_right